Rosenscheg, M. et al. 2026. 525 - USE OF NEOADJUVANT CHEMOTHERAPY AND DISSECTION OF THE POSITIVE SENTINEL LYMPH NODES IN THE TREATMENT OF BREAST CANCER ONLY ON STAGES T1 TO T2 . Mastology. 32, suppl.1 (Mar. 2026). DOI:https://doi.org/10.29289/259453942022V32S1082.